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Abstract
Griseofulvin (1) is a spirocyclic fungal natural product used in treatment of fungal dermatophytes. 
Formation of the spirocycle, or the grisan scaffold, from a benzophenone precursor is critical for 
the activity of 1. In this study, we have systematically characterized each of the biosynthetic 
enzymes related to the biogenesis of 1, including the characterization of a new polyketide synthase 
GsfA that synthesize the benzophenone precursor and a cytochrome P450 GsfF that performs 
oxidative coupling between the orcinol and the phloroglucinol rings to yield the grisan structure. 
Notably, the finding of GsfF is in sharp contrast to the copper-dependent dihydrogeodin oxidase 
that performs a similar reaction in the geodin biosynthetic pathway. The biosynthetic knowledge 
enabled the in vitro total biosynthesis of 1 from malonyl-CoA using all purified enzyme 
components. This work therefore completely maps out the previously unresolved enzymology of 
the biosynthesis of a therapeutically relevant natural product
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Griseofulvin (1), a polyketide produced by ascomycetes such as Penicillium aethiopicum,1 is 
the first oral antifungal drug2-4 and has been in use for many years in medical and veterinary 
applications.5 While 1 is largely superseded by newer antifungal drugs such as azoles and 
echinocandins, 1 has a niche in treatment of dermatophytes such as tinea capitis (ringworm 
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of the scalp) and tinea pedis (athlete's foot). 1 recently gained medical attention due to its 
ability to disrupt mitotic spindle6 and act as potential inhibitor of centrosomal clustering7 in 
tumor cells. From a biosynthetic perspective, 1 occupies a place in the pantheon of natural 
products due to its significance in establishing the field of study of polyketide biosynthesis.8 
The acetate origin of the carbon skeleton of 1 was demonstrated through the feeding of 
[1-14C]-acetate to the griseofulvin-producing strain Penicillium griseofulvum Dierckx and 
the labeling pattern in 1 was determined using degradation experiments.9, 10 The polyketide 
hypothesis11 was further confirmed through feeding of singly and doubly [13C]-acetate 
followed by NMR analysis (Figure 1).12 In addition, the formation of the spirocyclic grisan 
ring of 1 was an examples used to illustrate the prevalence of phenol oxidative coupling 
reactions in Nature.13 Subsequent studies using feeding of the radiolabeled benzophenone 
intermediates griseopheone B (10) and C (11) implicated their role in the biosynthesis of 1 
and supported further suggests the requirement of oxidative coupling to form the grisan 
ring.14-16
Despite these pioneering studies, the genetic and biochemical basis of the biosynthetic 
pathways of 1 have been left unexplored. Considering the importance of 1 to the field of 
natural products, specifically the polyketide community, the complete understanding of how 
its carbon backbone is assembled and is subsequently transformed into 1 is therefore 
compelling. We recently sequenced the genome of P. aethiopicum to map its biosynthetic 
capacity.17 In addition to 1 and the related metabolite dechlorogriseofulvin (2), P. 
aethiopicum also produces viridicatumtoxin (3) and tryptoquialanine (4), two other 
secondary metabolites with spirocyclic moiety (Figure 1B).1, 17, 18 Bioinformatic mining of 
the P. aethiopicum genome led to the discovery of the putative gsf cluster (Figure 1C), 
which contains gsfA, a gene for a non-reducing polyketide (NR-PKS) and genes for tailoring 
enzymes that appear consistent with the modifications required to form 1. Gene deletion of 
gsfA and flavin-dependent halogenase gene gsfI confirmed the association between gsf 
cluster and biosynthesis of 1.17 The enzymology of the NR-PKS, which synthesizes a 
polyketide backbone atypical to the characterized aromatic polyketides, and the enzymes 
involved in maturation of the griseofulvin scaffold structure, highlighted by the spirocyclic 
grisan ring, can now be studied using modern genetic and biochemical tools. In this work, 
we present the comprehensive single-gene knockout and in vitro reconstitution of every 
enzyme in the gsf pathway. These insights led to the in vitro synthesis of 1 from malonyl-
CoA using purified gsf enzymes and cofactors.
RESULTS AND DISCUSSION
GsfA is a norlichexanthone synthase
Our initial genetic studies with P. aethiopicum showed that gsfA, which encodes a 
thioesterase (TE)-less NR-PKS, is required to produce the heptaketide backbone of 1.17 To 
biochemically investigate the role of GsfA, gsfA cDNA was cloned into the YEpLac195 
yeast-E. coli shuttle vector driven by the ADH2 promoter. The resulting YepLac195-GsfA 
construct was transformed into S. cerevisiae BJ5464-NpgA strain, which contain a 
chromosomal copy of npgA, the phosphopantetheine transferase gene from Aspergillus 
nidulans which post- translationally installs the phosphopantetheine arm to the acyl carrier 
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protein (ACP) domain of PKS.19 Intact holo-GsfA (185 kDa) with a C-terminal His-tag was 
purified to near homogeneity to a final titer of 2 mg/L of yeast culture.
To assay the activity of recombinant GsfA, we incubated the enzyme with either malonyl-
CoA directly or with an in situ malonyl-CoA generation system (Figure 2). Furthermore, 
since GsfA lacks a TE domain that may release the mature polyketide product and no 
standalone TE is found in the gene cluster, we incubated GsfA with a promiscuous TE 
domain from the hypothemycin NR-PKS Hpm3.20 Surprisingly, GsfA alone was sufficient 
for the production and release of a predominant product 5 with m/z=259, [M+H]+ (Figure 2). 
Addition of the Hpm3 TE domain did not enhance the turnover of the product 5. To purify 
sufficient amount of 5 for structural characterization, we cultured the BJ5464-NpgA strain 
expressing GsfA, which was able to produce 5 at a final titer of 10 mg/L. Compound 
purification followed by NMR characterization identified 5 as norlichexanthone (Figure 2), 
which bears the expected heptaketide backbone.
A typical NR-PKS contains starter-unit-ACP transacylase (SAT),21 ketosynthase (KS), 
malonyl-CoA-ACP transacylase (AT), product template (PT),22, 23 ACP and TE 
domains.24-28 The cyclization regioselectivity of the nascent polyketide chain is determined 
by the functions of the PT and the TE domains.22-24 The PT domain, in particular, mediates 
the regioselective aldol-type cyclization through steric interactions with the newly-formed 
polyketide.22, 23 Using phylogenetic analysis and domain shuffling experiment, we 
previously classified ~100 PT domains into distinct clades based on ring size and first aldol 
condensation regioselectivity.29 Interestingly, the GsfA PT does not classify into any of the 
clades, in correspondence with its unique cyclization selectivity. Indeed, based on previous 
labeling studies and the biochemical studies using purified GsfA, we can conclude that GsfA 
PT must catalyze the unusual C8-C13 aldol condensation as the first cyclization step in the 
formation of 5.
The enzymatic basis of the Claisen-like condensation (C1-C6) to afford the phloroglucinol 
ring, however, is unclear. GsfA belongs to a TE-less NR-PKS, of which no terminal TE 
domain is found in the NR-PKS. For TE-less NR-PKSs, a standalone β-lactamase-like 
enzyme is typically present in the gene cluster to release the product either through 
hydrolysis or Claisen-like condensation.30 No gene for such releasing enzyme is present in 
the gsf cluster, and our reconstitution studies show that GsfA alone is able to turnover 
products. Therefore the activities to catalyze the C1-C6 cyclization must be within the GsfA 
NR-PKS. It is reasonable to propose that because of the smaller size of the polyketide, the 
PT domain, when distorting the polyketide backbone for the aldol cyclization, may also 
promote the C1-C6 cyclization in its active site. Hence, formation of 5 represents an 
intriguing example in which a NR-PKS performs a Claisen-like cyclization without using a 
dedicated, in-line or dissociated TE. While the two cyclization events in the biosynthesis of 
5 (and 5a) are unusual, it is far from unique. To wit, compounds bearing the 
norlichexanthone scaffold have been isolated from lichens.31 Thus one can reasonably 
speculate that a GsfA homolog may be found in the fungal symbionts in the lichens that 
produce compounds related to 5.
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Methylation of GsfA product by GsfB and GsfC hinders xanthone formation
Although the xanthone 5 is detected as the only polyketide product from the in vitro assay, it 
is most likely that the true heptaketide product of GsfA is the benzophenone 5a (Table 1), 
which can undergo a spontaneous dehydration to form 5. Formation of the grisan structure in 
1 must proceed through the intermediate 5a, thereby making 5 a likely off-pathway shunt 
product. Indeed, feeding of 5 to the ΔgsfA mutant did not restore the production of 1 (Figure. 
S1), thereby ruling out the possibility of 5 undergoing rehydration to open the xanthone ring 
and form 5a during biosynthesis of 1. We hypothesize that the methylation of the phenols in 
5a, especially at 9-OH may hinder dehydration and suppress xanthone formation. To 
investigate this hypothesis, genetic inactivation and in vitro reconstitution of the three O-
methyltransferases (MTs) GsfB, GsfC and GsfD were performed. Deletion of gsfB led to the 
production of 5 as a minor product, 7 (obs. m/z= 291, [M+H]+), 8 (obs m/z= 325, [M+H]+), 
and 9 (obs. m/z= 337, [M+H]+) (Figure 3, ii). Elucidation of the structures of the compounds 
using 1D 1H and 13C and 2D HSQC and HMBC NMR revealed the identity of 7 as 
griseophenone E, 8 as griseophenone F and 9 as desmethyl-dehydrogriseofulvin B. 7-9 share 
the characteristic lack of methylation at 3-OH, suggesting that GsfB is the 3-OH MT. The 
isolation of 9 also suggests that downstream steps, including the formation of the grisan 
structure, are not dependent on the 3-OH methylation step. On the other hand, the ΔgsfC 
mutant showed 5 as a more prominent product in comparison to the metabolic profile of the 
ΔgsfB, along with 6 (obs. m/z = 291, [M+H]+), 16 (obs. m/z = 273, [M+H]+) and 17 (obs. 
m/z= 325, [M+H]+), which were identified as griseophenone D, griseoxanthone C and 
griseophenone H respectively (Figure 3, iv). In contrast to the metabolites found in ΔgsfB 
mutant, 6, 16 and 17 are methylated at 3-OH, but lack methylation at 9-OH, thereby 
confirming that GsfC is the 9-OH MT. Isolation of these benzophenone intermediates in the 
ΔgsfB and ΔgsfC mutants confirms our hypothesis that methylations at 3-OH and more so at 
9-OH, can suppress the formation of the off-pathway shunt product 5.
In order to verify the roles of the MTs, in vitro assay of GsfA together with each of the 
recombinant MT was performed. The coupled reaction with GsfA generates the labile 
benzophenone 5a in situ that serve as substrates for the MTs. Assay containing GsfA and 
GsfB produced predominantly xanthones 5 and 16, as well as 6, demonstrating partial 
suppression of dehydration after methylation of 3-OH (Figure 3, v). Presumably, 6 
undergoes dehydration to form 16. Alternatively, the nascent polyketide product of GsfA 
undergoes dehydration to 5 followed by methylation by GsfB to form 16. The coupled assay 
of GsfA with GsfC, on the other hand, produced predominantly 7 as expected, with a trace 
amount of 5, further confirming the 9-OH methylation step as a means to keep the GsfA 
product 5a on pathway during biosynthesis of 1 (Figure 3, iii). Taken together, these studies 
with MTs confirm that the GsfA product undergoes methylation by both GsfB and GsfC 
before forming the grisan ring, which is in agreement of the previous feeding studies.14, 15
On the other hand, knockout of gsfD yielded the production of grisan-containing compounds 
desmethyl-dechlorogriseofulvin (13) (obs. m/z = 305, [M+H]+), desmethyl-
dehydrogriseofulvin A (14) (obs. m/z = 337, [M+H]+), and desmethyl-griseofulvin (15) (obs. 
m/z = 339, [M+H]+) (Figure 4, iii). These metabolites represent late-stage shunt products (13 
and 15) and intermediate (14) during the formation of 1. The structures of 13-15 show the 
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lack of methylation at the 5-OH position, implying that GsfD regioselectively targets 5-OH. 
Based on these results, we propose the role of GsfD is to methylate of 14 to produce 
dehydrogriseofulvin (18).
Biochemical confirmation of the role of GsfI
Previously, loss of 1 and sole production of 2 were observed when the gene gsfI encoding 
the flavin-dependent halogenase was deleted in P. aethiopicum.17 To biochemically 
reconstitute the halogenation reaction, we cloned, expressed and purified GsfI and 
performed an in vitro assay using 10, the proposed intermediate from the previous labeling 
studies,15 as substrate. In order to regenerate the reduced flavin cofactor of GsfI, the 
NADPH-dependent flavin reductase SsuE was added to the reaction. As expected, assay of 
the non-chlorinated 10 with GsfI led to the production of chlorinated phenone 11 at ~50% 
conversion(Figure S4), reflecting the ratio of the chlorinated final compound 1 and its 
dechlorinated counterpart 2 in the original host.
GsfF performs phenolic coupling to afford the grisan scaffold
Oxidation of the phenone ring to form the grisan ring dramatically transforms the phenone 
scaffold of griseophenone B (11)into the spirocyclic grisan compound 14, thereby 
dearomatizing the orcinol ring of 11 and creating the cyclohexadienone in 14. An analogous 
reaction during biosynthesis of geodin in A. terreus was proposed to be catalyzed by copper-
centered enzyme dehydrogeodin oxidase.32 However, such a copper laccase enzyme is not 
encoded in the gsf cluster, thus we proposed that the cytochrome P450 (CYP) GsfF may 
instead catalyze the phenolic coupling reaction of 11 to afford 14.17 To probe the role of 
GsfF, we deleted gsfF in P. aethiopicum and characterized the resulting metabolites via LC-
MS and NMR. The ΔgsfF strain produced griseophenone C (10) (obs. m/z = 305, [M+H]+), 
monochlorinated 11 (obs. m/z = 339, [M+H]+) and dichlorinated griseophenone G (12) (obs. 
m/z = 373, [M+H]+) (Figure 4, ii). Accumulation of 10 and 11 as major intermediates 
supports the coupling role of GsfF in the pathway. The degrees of chlorination of the 
metabolites were further ascertained based on the presence of the expected 3:1 isotopic 
distribution of the monochlorinated 11 and the 1.5:1 isotopic distribution of the 
dichlorinated 12 (Supporting Information). The C2-regioselectivity of the first chlorination 
reaction was determined by the loss of the symmetry along the C3-C6 axis of 11 in 
comparison to 10, as evident in comparative NMR analysis. The symmetry along C3-C6 
axis as shown in the NMR spectra was restored upon further chlorination of 11 to afford 12, 
thus confirming the regioselectivity of the second chlorination at C4.
To functionally confirm the role of GsfF, the CYP was expressed in S. cerevisiae BJ5464-
NpgA strain together with the A. terreus CYP oxidoreductase (CPR) using Gal1 and Gal10 
bidirectional promoter,33 allowing the temporal coexpression of the CYP and the CPR that 
is required for turnover of the CYP. Following induction of GsfF and CPR expression, 11 
was supplemented to the yeast culture at a final concentration of 1 μM. The organic 
metabolites were extracted twenty-four hours later with ethyl acetate and analyzed by 
LCMS. S. cerevisiae cells expressing both CPR and GsfF were able to completely convert 
11 to a product that is identical (UV, mass and retention time) to 14 isolated from ΔgsfD 
mutant (Figure 5, ii). In contrast, yeast cells expressing only CPR did not show any 
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conversion of 11(Figure 5, i). To further prove the conversion of 11 to 14 is catalyzed by 
GsfF, microsomal fraction from yeast cells coexpressing CPR and GsfF was isolated and in 
vitro assay was performed in the presence of NADPH. Microsomes containing both GsfF 
and CPR facilitated 90% conversion of 11 to 14 after overnight incubation (Figure 5, iv). 
Time course kinetics of GsfF revealed conversion of 11 to 14 at a turnover rate of 0.437 μM 
min−1·mg−1 of microsomal protein (Supporting Information). In contrast, identically 
prepared microsomes containing only CPR did not shown any conversion (Figure 5, iii). 
Therefore, we unequivocally confirmed the role of GsfF in the oxidative formation of the 
spirocyclic grisan.
In this coupling reaction, the orcinol ring is contorted leading to the metamorphosis of the 
di-aromatic 11 into the tricyclic 14. Based on the feeding studies in the biosynthesis of 1 
using [1,1-18O]-labeled acetate, all of the oxygen atoms in 1 originated from acetate.34 
Based on known reactions catalyzed by cytochrome P450, one can propose two different 
mechanisms for GsfF reaction (Scheme 2): A.) a di-radical mechanism and B.) a mechanism 
involving the formation of an arene oxide intermediate (11b). In the first mechanism, the 
reaction is initiated by the formation of Compound I, the active form of the heme cofactor of 
GsfF. Compound I then abstracts a hydrogen atom from 11 to form the resonance-stabilized 
phenoxy radical on the orcinol ring. Thereafter, Compound II form of GsfF abstracts the 
second hydrogen atom from 11a to form the phenoxy radical on the phloroglucinol ring with 
water as the by-product of the reaction. The incipient phloroglucinol radical then couples 
with the orcinol radical in a stereospecific fashion to form 14. This di-radical mechanism, 
first envisioned by Barton and Cohen,13 has also been proposed for the mechanisms of the 
coupling between the isoquinoline and phenolic rings in reticuline by salutaridine synthase 
during morphine biosynthesis,35 the coupling of the two indole rings of chromopyrrolic acid 
by StaP to form indolocarbazole in the biosynthesis of staurosporine,36 and the dimerization 
of coniferyl alcohol monomers in the biosynthesis of lignin.37 Incidentally, both salutaridine 
synthase and StaP are CYP-type oxygenases as well.35, 36 Moreover, this proposed 
mechanism is in agreement with the [1,1-18O]-acetate labeling study since all oxygen atoms 
are retained during the transformation of 11 to 14.34
Alternatively, the oxidation of 11 by GsfF can go through an arene oxide intermediate (11b), 
which will then be subjected to nucleophilic attack by the hydroxyl of the phloroglucinol 
ring to form 11c. The hemiacetal intermediate then undergoes dehydration to afford 14. 
During the dehydration of the hemiacetal intermediate, the oxygen atom that originated from 
molecular oxygen is removed. Thus, this mechanism agrees as well with the labeling 
studies.34 An analogous mechanism was proposed, along with a di-radical mechanism, in 
the ring coupling reaction by the CYP OxyB in the biosynthesis of the vancomycin family of 
antibiotics.38, 39
GsfE performs stereospecific reduction of enol 18 to afford the final product 1
Having functionally characterized the PKS GsfA, the MTs GsfB-D, the chlorinase GsfI and 
the P450 GsfF, the only uncharacterized biosynthetic step in the pathway is reduction of the 
cyclohexadienone ring in 18 or dechloro-dehydrogriseofulvin (19) to afford 1 or 2, 
respectively. Two of the remaining uncharacterized genes in the cluster, gsfE and gsfK; are 
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for proteins that contain a conserved binding site for a nicotinamide cofactor and one of 
these may be capable of performing the final enoylreduction. Thus, single gene deletion 
mutants of gsfE and gsfK were constructed followed by metabolite analysis. All of the ΔgsfK 
mutants isolated retained the ability to produce 1 and 2. On the other hand, knockout of gsfE 
led to the production of 18 and 19 (Figure 4, iv), both of which were structurally verified by 
extensive NMR characterization (Supporting Information). Interestingly, while initial 
bioinformatic analysis of GsfE suggested that it is related to nucleoside-sugar epimerases 
based on sequence alignment, further analysis of the GsfE protein sequence via structural 
homology prediction revealed that it shares an overall folding, as well as conserved catalytic 
lysine and tyrosine as the progesterone-5β-reductase (POR) from the cardenolide 
biosynthetic pathway in Digitalis lanata.40 POR catalyzes the stereospecific reduction of 
progesterone to form 5β-pregnane-3,20-dione, a reaction that is analogous to the reduction 
of the cyclohexadienone ring of 18 to form 1. To verify the genetic and bioinformatic 
results, we reconstituted the reaction in vitro using His-tag fused-GsfE expressed and 
purified from E. coli BL21 (DE3), and 18 or 19 as substrates. NADPH was added as the 
reducing cofactor of GsfE. As shown in Figure 6A and Figure S5, GsfE fully converted 18 
or 19 to 1 or 2, respectively, thereby confirming its role as the last enzyme in the pathway. 
Moreover, this confirms GsfE performs a 1,4- (Michael-type) hydride addition instead a 1,2-
addition performed by nucleoside sugar epimerases (Figure 6B).
Total in vitro biosynthesis of 1 and 2
Upon identifying all enzymatic components of the biosynthetic pathway, we attempted in 
vitro synthesis of 1 and 2 using purified Gsf enzymes (see Methods). Incubation of GsfA-F 
with malonyl-CoA, SAM and NADPH in PBS resulted in the expected production of 2 as a 
major product, along with 5, 10 and 13. Addition of GsfD-F after three-hour preincubation 
of GsfA-C with malonyl-CoA and SAM led to the production of 2 and 10 only. Finally, 
addition of the chlorinase GsfI and SsuE together with GsfA-F led to the production of the 
desired product 1 as a major product along with 2, 10, 11 and griseophenone A (20) (Figure 
7, iii). The final yield of of 1 with respect to malonyl-CoA was ~1%. The presence of 10 and 
11 in all assays indicate the microsomal GsfF-catalyzed oxidative coupling is the rate 
limiting step in the multi-enzyme reactions.
Based on the results from the genetic and enzymatic data, we can establish the individual 
steps in the biosynthetic pathway for 1 (Scheme 3). The biosynthesis is initiated by the 
formation of the heptaketide by GsfA using one acetyl-CoA starter unit and six malonyl-
CoA extender units. Thereafter, the product template (PT) domain of GsfA catalyzes the 
unprecedented C8-C13 aldol-type cyclization followed by C1-C6 Claisen-type cyclization to 
form 5a, wherein dehydration of 5a can readily take place in the absence of downstream 
steps to form the xanthone shunt product 5. Meanwhile, on pathway processing of 5a 
continues through the methylation at 3-OH and 9-OH by GsfB and GsfC, respectively, to 
form 10. Although feeding studies by Harris et al. suggest that 3-OH methylation has 
priority over 9-OH methylation,16 results from the knockout of gsfB and gsfC indicate that 
either can perform the first methylation reaction on the GsfA product 5a. Following the two 
methylation steps, 10 undergoes chlorination by the flavin-dependent halogenase GsfI to 
form 11. Following chlorination, 11 undergoes phenolic ring coupling by the cytochrome 
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P450 GsfF to form the grisan compound 14. Subsequently, 14 is subjected to two additional 
tailoring steps: methylation at 5-OH and reduction of the cyclohexadienone to afford 1. 
Based on the presence of 14 in the ΔgsfD mutant, indicating the inefficient reduction by 
GsfE of the 5-OH-desmethyl substrates, it can be proposed that methylation by GsfD to 
yield 18 takes place before GsfE-catalyzed enoylreduction, which is in agreement with 
previous feeding studies on the biosynthesis of 1.14-16, 34 The chlorination step by GsfI is 
apparently incomplete in P. aethiopicum and in vitro (Figure 7). Enzymes downstream of 
GsfI, including GsfF, GsfD and GsfE, can all act on the respective dechlorinated substrates 
to yield the final product 2. In conclusion, we performed comprehensive single-gene 
deletion of the gsf genes and functional characterization of the corresponding enzymes to 
elucidate the biosynthetic pathway of 1. Several grisan analogues of 1 were isolated from the 
different gene deletion mutants (Scheme 1), hinting at the overall flexibility of the pathway 
and its potential for biosynthetic engineering. Moreover, this study has uncovered the novel 
and interesting reactions within this pathway, such as the unorthodox C1-C6 and C8-C13 
cyclization of 5a by GsfA, and P450-mediated ring coupling reaction of the orcinol and 
phloroglucinol rings of 11 to form 14. These two reactions warrant further mechanistic 
investigations that may possibly lead to a better understanding of the biosynthesis of natural 
products with similar features.
MATERIALS AND METHODS
In vitro assay of GsfA
For the in vitro synthesis of 5, 10 μM GsfA was incubated with 2 mM malonyl-CoA and 15 
μM tailoring enzyme (Hpm TE, GsfB, GsfC or GsfD) in 100 mM phosphate buffered saline 
pH 7.4 in a 100 μL reaction. The reaction was incubated overnight and extracted twice with 
ethyl acetate. For the reactions using malonyl-CoA generated in situ by MatB, the assay was 
done essentially the same as above except malonyl-CoA was substituted with 20 μM MatB, 
5mM CoA, 100 mM malonate, 5 mM MgCl2, 5mM DTT and 20 mM ATP. The organic 
phase was dried and dissolved in 20 μL methanol and subjected to LCMS analysis as 
described in Supplemental Information.
Chemical analysis and compound isolation from P. aethiopicum gene deletion mutants
For small-scale secondary metabolic profile analysis, the P.aethiopicum wild-type and 
transformants were grown in 10-20 mL YMEG liquid medium for 7 days at 28 °C without 
shaking. The cultures were extracted with equal volume of ethyl acetate with 1% acetic acid, 
evaporated to dryness and redissolved in methanol for LCMS analysis in the same manner 
as the in vitro characterization of GsfA (). For preparative scale compound isolation, gene 
deletion strain of P.aethiopicum was grown in 3 L YMEG in the same manner as the small-
scale cultures. The culture was extracted twice with equal volume of ethyl acetate and was 
evaporated to dryness and subjected to Sephadex and HPLC purification and NMR 
characterization in the same manner as 5.
In vitro assay of GsfI
The assay for the chlorinase was done essentially the same as described in Zhou et al.41 
Briefly, 50 μM of GsfI was incubated with 200 μM Griseophenone C (10) in 100 mM 
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sodium phosphate buffer (pH 7.4) and 50 mM NaCl. In order to regenerate the reduced 
flavin in GsfI, the flavin reductase SsuE (15 μM), FAD (5 μM) and NADPH (2 mM) were 
added to the reaction mix. After overnight incubation, the reaction mix was extracted twice 
with equal volume ethyl acetate, dried in vacuo and subjected to LCMS analysis as 
described above for 5.
In vitro assay of GsfE
For in vitro synthesis of 1 from 18, 10 μM of GsfE was incubated with 100 μM and 1 mM 
NADPH in 100 mM Tris-HCl (pH 7.5) buffer and 100 μL reaction volume. After 5 hour 
incubation in room temperature, the reaction mix was extracted twice with equal volume of 
ethyl acetate, dried in vacuo and analyzed by LCMS in the same manner as 5 .
Total in vitro biosynthesis of 1 and 2
For the total in vitro synthesis of 2, 4 μM of GsfA, 2 μM each of the methyltransferases 
(GsfB, GsfC and GsfD), 2 μL of microsomal protein containing GsfF and AtCPR and 2 μM 
of GsfE were incubated with 2 mM of malonyl-CoA, 100 μM of S-adenosyl methionine and 
2 mM of NADPH in 100 μL reaction mix buffered with 100 mM sodium phosphate (pH 7.4) 
and 50 mM NaCl. After overnight incubation, the reaction mix was extracted twice with 
equal volume ethyl acetate, dried and subjected to the same LCMS analysis as 5 (vide 
supra). The total in vitro biosynthesis of 1 was done in the same manner as 2, except GsfA-
C were incubated with 10 μM of GsfI and 2 μM SsuE for 3 hours prior to addition of GsfF, 
GsfE and GsfD. The total yield of 1 was measured by comparing the area under the 
chromatogram peak of 1 against a standard curve of known amount of 1 injected and 
analyzed by LCMS.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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NADPH nicotinamide adenine dinucleotide phosphate (reduced)
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Shunt products and intermediates that contain the grisan scaffold.
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Putative mechanisms of the orcinol and phloroglucinol ring coupling by GsfF. A.) Di-radical 
ring coupling mechanism of GsfF. B.) Alternative mechanism for the ring coupling 
involving an arene oxide intermediate.
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Biosynthetic pathway of 1.
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Griseofulvin (1) and other secondary metabolites produced by Penicillium aethiopicum. A.) 
The structure of 1 and dechlorogriseofulvin (2) shown together with the acetate origin of 
carbon and oxygen atoms. B.) Viridicatumtoxin (3) and tryptoquialanine (4) are the other 
chemotaxonomic marker in P. aethiopicum; and C.) Arrangement of genes in the 
biosynthetic gene cluster of 1 in P. aethiopicum.
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GsfA catalyzes formation of 5 from malonyl-CoA as confirmed by HPLC analysis. i.) No 
GsfA control ii.) GsfA and the excised TE domain of Hpm3 incubated with in situ generated 
malonyl-CoA. iii.) GsfA incubated with in situ generated malonyl-CoA using MatB, 
malonate, CoA and ATP. iv.) GsfA incubated with malonyl-CoA only.
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The O-methyltransferases GsfB and GsfC tailor the nascent GsfA product. i.) Secondary 
metabolic profile of Penicillium aethiopicum showing the production of 1-4. ii.) Deletion of 
gsfB led to the production of 5, 7, 8, and 9. iii.) Coupled in vitro assay of GsfA and GsfC led 
to the production of 7 thereby confirming 9-OH regioselectivity of GsfC iv.) Deletion of 
gsfC led to the production of 5, 6, 16 and 17. v.) Coupled in vitro assay of GsfA and GsfB 
led to the production of 5, 6 and 16 thereby confirming the 3-OH regioselectivity of GsfB.
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Tailoring reactions in biosynthesis of 1. i.) Wild-type P.aethiopicum showing the production 
of 1-4. ii.) Knockout of cytochrome P450 gene gsfF led to the production of the 
dimethylated phenones 10, 11 & 12 containing different degrees of chlorination. iii.) 
Knockout of the O-methyltransferase gsfD led to the production of 13, 14 and 15. iv.) 
Knockout of the short-chain dehydrogenase /reductase gene gsfE led to the production of 18, 
and 19.
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The cytochrome P450 GsfF catalyzes the coupling of orcinol and phloroglucinol rings in 
griseophenone B (11) to form desmethyl-dehydrogriseofulvin A(14). i.) BJ5464-NpgA 
expressing CPR only did not convert 11 to 14. ii.) BJ5464-NpgA expressing both CPR and 
GsfF completely converted 11 to 14 after 24 hours. iii.) Yeast microsomes containing CPR 
do not convert 11 in vitro. iv.) Yeast microsomes containing both CPR and GsfF converted 
11 to 14 in the presence of NADPH. v.) Standard of 14 purified from ΔgsfD deletion strain.
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Verifying the activity of GsfE. A.) Incubation of 18 with 10 M GsfE and 1 mM NADPH led 
to the production of 1. B.) Putative mechanism of GsfE showing the stereospecific 1,4-
(Michael) addition of the hydride from NADPH to 18, followed by protonation of the 
resulting cyclohexadienolate to form 1.
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In vitro total biosynthesis of 1 and 2. i.) GsfA-F, SAM and malonyl-CoA added in one step. 
ii.) GsfA-C, SAM and malonyl-CoA incubated together for 3 hours prior to addition of 
NADPH, GsfF ,GsfD and GsfE. iii.) GsfA-C, GsfI, SsuE, SAM, malonyl-CoA and NADPH 
incubated together for 3 hours prior to addition of GsfF, GsfD and GsfE.
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Table 1
Putative functions of the genes in the 1 biosynthetic pathway and identified metabolites from single-gene 
knockout strains.
*




gsfB (3-OH) O-methyltransferase 5, 7, 8, 9
gsfC (9-OH), O-methyltransferase 6, 16, 17
gsfD (5-OH), O-methyltransferase 13, 14, 15
gsfE short-chain dehydrogenase/reductase 18, 19
gsfF cytochrome P450 10, 11, 12
gsfI halogenase 2 
*
gsfK ketoreductase 1, 2
*
Knockout of gsfA and gsfI was reported in a previous study by our group (ref 17).
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Table 2
Griseophenones characterized in this study.
Compound R1 R2 R3 R4 R5
5a H H H H H
griseophenone D (6) H Me H H H
griseophenone E (7) H H H H Me
griseophenone F (8) Cl H H H Me
griseophenone C (10) H Me H H Me
griseophenone B (11) Cl Me H H Me
griseophenone G (12) Cl Me Cl H Me
griseophenone H (17) Cl Me H H H
griseophenone A (20) Cl Me H Me Me
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